EDWARD OVERTON: Open Payments
NPI 1093753329 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 23 payments from 11 companies in 2025. Trend: 2023 $576 · 2024 $507 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $93 |
| Forte Bio-Pharma LLC | 4 | $90 |
| Virtus Pharmaceuticals LLC | 3 | $49 |
| Indivior Inc. | 2 | $47 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Braeburn Inc. | 2 | $46 |
| Tonix Medicines, Inc. | 2 | $38 |
| SCILEX PHARMACEUTICALS INC. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, PROLATE, LEVORPHANOL TARTRATE, SUBLOCADE, JOURNAVX, BRIXADI, TONMYA, ELYXYB - CELECOXIB.
Industry payments across NC — which companies pay providers there.
